StockData
Biohaven Ltd. logo

Biohaven Ltd. (BHVN) stock

BHVNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 1/30
$12.90−0.34 (-2.57%)

Close on Nov 18, 2026Market cap $1.95BP/E –Yield –

Earnings

Biohaven's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Mar 1, 2027
Q4 FY2026 · estimated, after the close
Revenue, Q3 FY2026
–
Non-GAAP adjusted net loss per share, Q3 FY2026
-$0.73
-$1.47 a year earlier
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Biohaven's earnings releases, newest first

QuarterReportedRevenueYoYEPSAdj. EPSSource
Q4 FY2026ended Dec 31, 2026Mar 1, 2027Expected–––––
Q3 FY2026ended Sep 30, 2026Oct 29, 2026after the close––-$0.86-$0.73Release
Q2 FY2026ended Jun 30, 2026Aug 10, 2026after the close––-$0.91-$0.78Release
Q1 FY2026ended Mar 31, 2026May 4, 2026after the close––-$0.88-$0.69Release
Q4 FY2025ended Dec 31, 2025Mar 2, 2026after the close––-$1.21-$0.90Release
Q3 FY2025ended Sep 30, 2025Nov 10, 2025before the open––-$1.64-$1.47Release
Q2 FY2025ended Jun 30, 2025Aug 11, 2025after the close––––Release
Q1 FY2025ended Mar 31, 2025May 12, 2025after the close––-$2.17-$1.64Release
Q4 FY2024ended Dec 31, 2024Mar 3, 2025after the close––$1.85$1.71Release
Q3 FY2024ended Sep 30, 2024Nov 12, 2024after the close––-$1.70-$1.74Release
Q2 FY2024ended Jun 30, 2024Aug 8, 2024after the close––-$3.64-$3.50Release
Q1 FY2024ended Mar 31, 2024May 9, 2024after the close––-$2.20-$1.77Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Biohaven has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Biohaven puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Biohaven filed with the SEC as exhibits to Form 8-K or 6-K

  1. Update
  2. Results
  3. Update
  4. Update
  5. Results
  6. Update
  7. Update
  8. Update
  9. Results
  10. Results
  11. Update
  12. Results
  13. Results
  14. Update
  15. Update

See a number that looks wrong?